We are live on
!
Find out more
CIP
Convergence Investment Partners Portfolio holdings
AUM
$1.06B
1-Year Est. Return
87.75%
This Fund
S&P 500
This Quarter
Est. Return
+1.09%
1 Year Est. Return
+87.75%
3 Year Est. Return
+284.26%
5 Year Est. Return
+379.02%
10 Year Est. Return
+1,390.46%
AUM
$768M
AUM Growth
+$22.8M
(+3.1%)
Cap. Flow
+$26.3M
Cap. Flow
% of AUM
3.42%
Top 10 Holdings %
Top 10 Hldgs %
13.16%
Holding
1,093
New
800
Increased
114
Reduced
121
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$5.93M |
| 2 |
CACI
CACI
|
+$5.05M |
| 3 |
CELG
Celgene Corp
CELG
|
+$4.9M |
| 4 |
Yelp
YELP
|
+$4.72M |
| 5 |
Norfolk Southern
NSC
|
+$4.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teradata
TDC
|
+$6.01M |
| 2 |
Gilead Sciences
GILD
|
+$5M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$4.91M |
| 4 |
Copa Holdings
CPA
|
+$4.6M |
| 5 |
Lowe's Companies
LOW
|
+$4.43M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.19% |
| 2 | Technology | 14.55% |
| 3 | Healthcare | 13.55% |
| 4 | Industrials | 12.49% |
| 5 | Consumer Discretionary | 11.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Travelers Companies
TRV
$80.2B
| $123K | 0.02% |
+886
| New | +$124K |
|
327
Colgate-Palmolive
CL
$74.4B
| $122K | 0.02% |
+1,697
| New | +$122K |
|
328
Progressive
PGR
$125B
| $122K | 0.02% |
+1,999
| New | +$114K |
|
329
HCA Healthcare
HCA
$89.5B
| $121K | 0.02% |
+1,247
| New | +$121K |
|
330
Cognizant
CTSH
$26B
| $117K | 0.02% |
+1,450
| New | +$115K |
|
331
Deere & Co
DE
$168B
| $116K | 0.02% |
+745
| New | +$121K |
|
332
Charter Communications
CHTR
$18.2B
| $114K | 0.01% |
+365
| New | +$128K |
|
333
PayPal
PYPL
$50.5B
| $114K | 0.01% |
+1,506
| New | +$119K |
|
334
American International
AIG
$41.3B
| $113K | 0.01% |
+2,084
| New | +$123K |
|
335
Allstate
ALL
$67.5B
| $113K | 0.01% |
+1,193
| New | +$116K |
|
336
Marriott International
MAR
$92.3B
| $112K | 0.01% |
+827
| New | +$116K |
|
337
Becton Dickinson
BDX
$48.2B
| $111K | 0.01% |
+525
| New | +$115K |
|
338
Biogen
BIIB
$30.7B
| $110K | 0.01% |
+401
| New | +$124K |
|
339
Macy's
M
$6.68B
| $109K | 0.01% |
+3,677
| New | +$99.3K |
|
340
American Airlines Group
AAL
$10.6B
| $107K | 0.01% |
+2,056
| New | +$110K |
|
341
Duke Energy
DUK
$97.3B
| $107K | 0.01% |
+1,376
| New | +$106K |
|
342
Stryker
SYK
$130B
| $106K | 0.01% |
+661
| New | +$107K |
|
343
Crown Castle
CCI
$32.2B
| $105K | 0.01% |
+957
| New | +$104K |
|
|
SCHW
344
Charles Schwab
SCHW
$187B
| $104K | 0.01% |
+1,989
| New | +$107K |
|
345
Truist Financial
TFC
$64B
| $103K | 0.01% |
+1,975
| New | +$106K |
|
|
TFCF
346
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $101K | 0.01% |
+2,771
| New | +$101K |
|
347
Emerson Electric
EMR
$88.3B
| $100K | 0.01% |
+1,461
| New | +$104K |
|
348
Dollar General
DG
$27.9B
| $98K | 0.01% |
+1,053
| New | +$101K |
|
349
Automatic Data Processing
ADP
$108B
| $97K | 0.01% |
+858
| New | +$100K |
|
|
MON
350
DELISTED
Monsanto Co
MON
| $96K | 0.01% |
+823
| New | +$99K |
|
Similar funds
MWA
SFP
ECM
NRG
HW
LAM
BGIM
CIA
Convergence Investment Partners's Q1 2018 Portfolio in Review
As of Q1 2018, Convergence Investment Partners held 1,093 positions worth $768M, up 3.1% from $745M the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Convergence Investment Partners deployed $26.3M of net new capital in Q1 2018, opening 800 new positions and adding to 114 existing holdings. Its largest new stake was CACI: 34,563 shares worth $5.23M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Teradata, an estimated $6.01M trimmed.
- Convergence Investment Partners's largest Q1 2018 buy was CACI: 34,563 shares worth $5.23M.
- Convergence Investment Partners added most to Pfizer in Q1 2018, an estimated $5.93M increase.
- Convergence Investment Partners's biggest Q1 2018 reduction was Teradata, cutting an estimated $6.01M.
- Convergence Investment Partners fully exited Ingevity in Q1 2018, selling an estimated $3.95M.
- Convergence Investment Partners's ten largest holdings make up 13% of its $768M portfolio in Q1 2018.
- Convergence Investment Partners opened 800 new positions and closed 54 in Q1 2018.
- Convergence Investment Partners's portfolio value rose 3.1% quarter-over-quarter to $768M.
Based on Convergence Investment Partners's 13F filing for Q1 2018, filed 14 May 2018.